Inside The Modular Factory Set To Disrupt Cell Therapy | United States Of Automation

A startup, Solaris, is revolutionizing cell therapy manufacturing by creating automated modular factories. These factories can produce therapies for multiple patients simultaneously, reducing costs and improving access. Enhanced automation minimizes human error and contamination risks, promising better patient outcomes and transforming the healthcare landscape through efficient, scalable production of life-saving treatments.